AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 OCT 6 - (NewsRx.com & NewsRx.net) -- Centrally injected GLP-1 prevents some types of gastric mucosal damage.
According to a study from Turkey, "Glucagon-like peptide-1 (GLP-1) is accepted to be a peptide involved in the central regulation of gastrointestinal function, but its potential gastroprotective effect is not clear. The aim of this study was to investigate whether intracerebroventricularly injected GLP-1 has protective effects on gastric mucosal lesions induced by several models, and if yes, whether these effects are due to the gastric antisecretory effect of the peptide."
"GLP-1, which was injected in three different doses (1, 10, 100 ng/10 mcL; i.c.v.) to conscious rats, prevented the mucosal lesions induced by reserpine and ethanol, but did not prevent the gastric mucosal lesions induced by pyloric ligation," reported Naciye Isbil-Buyukcoskun and Guldal Gulec at Uludag University. "In addition, 1 ng/10 mcL dose of centrally injected GLP-1 inhibited gastric acid secretion in pylorus-ligated rats."
The researchers stated, "As a result, we conclude ...